Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum PsyBio Therapeutics Corp V.PSYB.H

Alternate Symbol(s):  PSYBF

Healthcare Biotechnology
PsyBio Therapeutics Corp. is a Canada-based biotechnology company. The Company is focused on discovering, designing and developing psycho-focused therapeutics to improve mental and neurological conditions. It is focused on understanding the value of tryptamines and other related psycho-targeted molecules as therapeutic candidates to improve mental and neurological health. The Company is engaged... see more

Bullboard (TSXV:PSYB.H)

View:
1 2 3 4 5 6 Next
Post by Jackstockon Jul 28, 2023 9:19am

While we wait here..

VEGA (PlantX)..Low share company 15m, good revenu last year and nice volume. 
76
Post by Betteryear2on Jul 21, 2023 10:37am

Awarded Approval to Manufacture Biosynthetic Tryptamines

Oxford, Ohio and Denver, Colorado--(Newsfile Corp. - July 21, 2023) - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) ("PsyBio" or the "Company"), an intellectual property ...more  
132
Comment by Bookworm28on Jul 13, 2022 2:06pm

RE:Meltdown?

Hmmm, now they're going to consolidate their stock on a potential/maximum basis of 1:70. I think this is the start of really good things to come. Clean out the old shareholders and bring in the ...more  
244
Discussion
Post by Bookworm28on Apr 15, 2022 12:54am

Meltdown?

Wow, just checking back on PSYB to see if there's anything new, and nadda. What happened to their website, and the people that were part of the research, development, and regulatory teams? What ...more  
492
Discussion
Post by lonadeon Mar 15, 2022 10:21am

News

PsyBio Therapeutics Announces Proposed Acquisition of Everest Pharma (Pty) Ltd., a Lesotho Company in Southern Africa, as Part of Its Ongoing Impact Investment Strategy well i have no clue what to ...more  
248
Comment by partystockeron Jan 05, 2022 4:08pm

RE:$ORIG to ipo super soon!

With the psychedelics industry currently resting at all time lows, now probably isn't the best time for Origin to hit the market. But the positive side of this is that Origin has a great ...more  
182
Discussion
Post by partystockeron Jan 02, 2022 3:30pm

$ORIG to ipo super soon!

The more I read about Origin Therapeutics the more excited I am for them to go public. Through a portfolio including both private and public companies, it’s going to give retail investors a great ...more  
256
Discussion
Post by partystockeron Dec 29, 2021 4:36pm

Still awaiting $ORIG ipo date- but that may be a good thing

As the end of Q4 draws nearer by the hour, it appears we won’t be getting a clear IPO date from Origin therapeutics. However, as the psychedelic market continues to see all-time lows, I don’t think ...more  
170
Comment by partystockeron Dec 23, 2021 4:34pm

RE:$ORIG- to IPO soon

Origin Therapeutics is still expected to go public before the end of Q4, giving retail investors an opportunity to invest in the private sector of the psychedelics market.    With ...more  
92
Discussion
Post by partystockeron Dec 19, 2021 5:36pm

$ORIG- to IPO soon

The therapeutic psychedelic industry is expected to grow at a CAGR of 16.3% to reach a market value of $10.75 billion by 2027. The rapidly increasing acceptance of psychedelic treatments is creating a ...more  
256
Discussion
Post by partystockeron Dec 15, 2021 11:55am

$ORIG worth keeping an eye on

With public acceptance of therapeutic psychedelics increasing, there are a few companies on my radar to watch in the immediate future. With business publications starting to hop on the trend now, it’s ...more  
144
Comment by PuerSimiaon Dec 09, 2021 8:45pm

RE:RE:RE:Holding Pretty Good

Hey BW, bad news. Jumped back in, and regretted it. Tax loss Season, so I sold out the other week. I see most of the co's in this sector have been in decline. Hope you've been having better ...more  
111
Discussion
Post by partystockeron Dec 07, 2021 2:28pm

$ORIG Investee TripSitter Trading on CSE

Origin Therapeutics’ (soon to IPO under the ticker $ORIG) portfolio company TripSitter commenced trading on the CSE late November.  Tripsitter has seen tremendous growth in the past year, and ...more  
147
Post by Betteryear2on Nov 19, 2021 8:14am

Furthers Intellectual Property Portfolio

Intellectual Property Filing and Protection Remains a Top Priority OXFORD, Ohio and COCONUT CREEK, Fla., Nov. 19, 2021  /CNW/ - PsyBio Therapeutics Corp. (TSXV: PSYB ...more  
135
Post by lonadeon Nov 09, 2021 7:14am

COMPASS Pathways announces positive topline results

big boost for the business model of Psybio! https://ceo.ca/@nasdaq/compass-pathways-announces-positive-topline-results
203
1 2 3 4 5 6 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities